BIOMAT Database Logo BIOMAT Database Logo

[Clinico-hemodynamic findings in obstructive hypertrophic myocardiopathy]. 1968

P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D007702 Kinetocardiography The graphic recording of chest wall movement due to cardiac impulses. Accelography,Apex Cardiography,Vibrocardiography,Cardiography, Apex,Accelographies,Apex Cardiographies,Cardiographies, Apex,Kinetocardiographies,Vibrocardiographies
D010701 Phonocardiography Graphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine. Phonocardiographies
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Obstructive hypertrophic myocardiopathy].
March 1977, Minerva pediatrica,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Hypertrophic obstructive myocardiopathy].
October 1965, Recenti progressi in medicina,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Immediate hemodynamic response to atrioventricular+ stimulation in severe hypertrophic obstructive myocardiopathy].
November 1996, Revista espanola de cardiologia,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Dermatomyositis and obstructive hypertrophic myocardiopathy].
September 1986, Medicina clinica,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Cineangiography in the hypertrophic obstructive myocardiopathy].
January 1974, Archivos del Instituto de Cardiologia de Mexico,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Obstructive hypertrophic myocardiopathy in the aged].
July 1978, Revista clinica espanola,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Hypertrophic myocardiopathy in the elderly: clinico-instrumental aspects].
January 1985, Giornale di clinica medica,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Hypertrophic obstructive myocardiopathy: surgical therapeutic options].
December 1993, Revue medicale de Liege,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Echocardiographic aspects of obstructive hypertrophic myocardiopathy].
January 1980, Bollettino della Societa italiana di cardiologia,
P L Malfanti, and L Salvatore, and M Rosselli, and A Massi, and L Santini, and P Baldelli, and M Zerauschek
[Obstructive hypertrophic myocardiopathy and coronary atherosclerosis].
January 1986, Archivos del Instituto de Cardiologia de Mexico,
Copied contents to your clipboard!